Measuring cannabis-related knowledge, attitudes, perceptions, motivations, and influences among women of reproductive age: a scoping review.
Marijuana
Perinatal
Pregnancy
Psychometric properties
Substance use
Journal
BMC women's health
ISSN: 1472-6874
Titre abrégé: BMC Womens Health
Pays: England
ID NLM: 101088690
Informations de publication
Date de publication:
27 03 2022
27 03 2022
Historique:
received:
23
07
2021
accepted:
14
03
2022
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
5
4
2022
Statut:
epublish
Résumé
Cannabis use among women of reproductive age has increased substantially in recent decades. Understanding reasons for cannabis use in this population is critical for cannabis use prevention efforts. Thus, this scoping review aimed to identify and synthesize current measures on reasons for cannabis use in women of reproductive age. We searched PubMed, PyschINFO, CINAHL, and Google Scholar for relevant studies published in English between January 2010 and April 2021. Peer-reviewed, quantitative studies reporting on measures of cannabis-related knowledge, attitudes, perceptions, motivations, and influences among women of reproductive age were eligible for inclusion. We excluded studies not focused on women of reproductive age and studies reporting cannabis use prevalence data only. We included 11 studies (10 primary studies and 1 review) with varying subpopulation samples of women, including non-pregnant women (n = 2), women experiencing infertility (n = 1), pregnant women (n = 4), postpartum women (n = 3), and women in the perinatal period (n = 1). Measurement topic areas included information received from health care professionals, attitudes, perceptions and experiences about cannabis use, knowledge of potential harms, and motivations for cannabis use. Most studies including measures of risk perceptions were conducted among pregnant or postpartum women (n = 4). A single study measured influences of cannabis use; no studies measured social or peer influences of use. Most studies (n = 7) created their own measures, with 2 studies using secondary data via measures from population-based surveillance systems in the United States, and one using a previously validated instrument. Recommendations for future research were centered around addressing knowledge gaps of health effects of cannabis use across different time periods, and etiology of cannabis use. We found vast measurement gaps in current measures of antecedents of cannabis use among women of reproductive age, providing clear direction for future research in this area. Findings necessitate psychometric evaluation of existing measures to ascertain validity and reliability, as well as development of additional measures of women's cannabis-related attitudes, perceptions, motivations, and influences. This work is critical to guide not only epidemiologic studies, but cannabis-related prevention work as well.
Sections du résumé
BACKGROUND
Cannabis use among women of reproductive age has increased substantially in recent decades. Understanding reasons for cannabis use in this population is critical for cannabis use prevention efforts. Thus, this scoping review aimed to identify and synthesize current measures on reasons for cannabis use in women of reproductive age.
METHODS
We searched PubMed, PyschINFO, CINAHL, and Google Scholar for relevant studies published in English between January 2010 and April 2021. Peer-reviewed, quantitative studies reporting on measures of cannabis-related knowledge, attitudes, perceptions, motivations, and influences among women of reproductive age were eligible for inclusion. We excluded studies not focused on women of reproductive age and studies reporting cannabis use prevalence data only.
RESULTS
We included 11 studies (10 primary studies and 1 review) with varying subpopulation samples of women, including non-pregnant women (n = 2), women experiencing infertility (n = 1), pregnant women (n = 4), postpartum women (n = 3), and women in the perinatal period (n = 1). Measurement topic areas included information received from health care professionals, attitudes, perceptions and experiences about cannabis use, knowledge of potential harms, and motivations for cannabis use. Most studies including measures of risk perceptions were conducted among pregnant or postpartum women (n = 4). A single study measured influences of cannabis use; no studies measured social or peer influences of use. Most studies (n = 7) created their own measures, with 2 studies using secondary data via measures from population-based surveillance systems in the United States, and one using a previously validated instrument. Recommendations for future research were centered around addressing knowledge gaps of health effects of cannabis use across different time periods, and etiology of cannabis use.
CONCLUSIONS
We found vast measurement gaps in current measures of antecedents of cannabis use among women of reproductive age, providing clear direction for future research in this area. Findings necessitate psychometric evaluation of existing measures to ascertain validity and reliability, as well as development of additional measures of women's cannabis-related attitudes, perceptions, motivations, and influences. This work is critical to guide not only epidemiologic studies, but cannabis-related prevention work as well.
Identifiants
pubmed: 35346156
doi: 10.1186/s12905-022-01673-6
pii: 10.1186/s12905-022-01673-6
pmc: PMC8961997
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
95Informations de copyright
© 2022. The Author(s).
Références
Addict Behav. 2019 Dec;99:106082
pubmed: 31421581
Hum Reprod Open. 2020 Feb 13;2020(1):hoz041
pubmed: 32072021
J Addict Med. 2017 May/Jun;11(3):211-216
pubmed: 28252456
Am J Obstet Gynecol. 2015 Aug;213(2):201.e1-201.e10
pubmed: 25772211
BJOG. 2020 Jan;127(1):8-16
pubmed: 31529594
J Hum Lact. 2021 Nov;37(4):803-812
pubmed: 33586506
Syst Rev. 2014 Jan 04;3:4
pubmed: 24387141
Women Birth. 2019 Feb;32(1):e57-e64
pubmed: 29673617
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
JAMA. 2017 Jan 10;317(2):207-209
pubmed: 27992619
J Stud Alcohol Drugs. 2020 Mar;81(2):203-211
pubmed: 32359050
J Obstet Gynaecol Can. 2020 Oct;42(10):1248-1253
pubmed: 31992503
Womens Health Issues. 2016 Jul-Aug;26(4):452-9
pubmed: 27131908
Am J Health Syst Pharm. 2008 Dec 1;65(23):2276-84
pubmed: 19020196
Can J Public Health. 2019 Feb;110(1):76-84
pubmed: 30387034
JAMA Netw Open. 2021 Feb 1;4(2):e210138
pubmed: 33630088
Obstet Gynecol. 2017 Oct;130(4):e205-e209
pubmed: 28937574
BMC Pregnancy Childbirth. 2017 Jun 29;17(1):203
pubmed: 28662645
CMAJ Open. 2020 Jul 31;8(3):E487-E495
pubmed: 32737023
Int J Womens Health. 2020 Nov 16;12:1075-1088
pubmed: 33235517
Obstet Gynecol. 2016 Apr;127(4):681-687
pubmed: 26959210
J Matern Fetal Neonatal Med. 2020 Dec 8;:1-9
pubmed: 33292026
BMC Med Res Methodol. 2018 Nov 19;18(1):143
pubmed: 30453902
Addict Behav. 2010 Nov;35(11):995-1000
pubmed: 20621423
J Addict Res Ther. 2012 Sep 30;3(4):
pubmed: 23858392
Dev Cogn Neurosci. 2018 Aug;32:80-96
pubmed: 29559216
Can J Public Health. 2021 Feb;112(1):49-59
pubmed: 32754880
Subst Use Misuse. 2018 Feb 23;53(3):357-369
pubmed: 28792283
J Obstet Gynaecol Can. 2020 Nov;42(11):1346-1350
pubmed: 32739359
Am J Obstet Gynecol. 2017 Dec;217(6):705-707
pubmed: 28843740
Subst Use Misuse. 2018 Dec 6;53(14):2339-2349
pubmed: 29944057
J Obstet Gynaecol Can. 2020 Jun;42(6):774-778
pubmed: 32001177
Sex Med. 2019 Jun;7(2):192-197
pubmed: 30833225
Prev Med. 2017 Nov;104:13-23
pubmed: 28705601
Prev Med. 2019 Feb;119:17-23
pubmed: 30552948